Log in

Eloxx Pharmaceuticals Stock Forecast, Price & News

-0.07 (-2.31 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $2.96
50-Day Range
MA: $2.84
52-Week Range
Now: $2.96
Volume22,046 shs
Average Volume122,595 shs
Market Capitalization$118.81 million
P/E RatioN/A
Dividend YieldN/A
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Read More
Eloxx Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.28 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolOTCMKTS:ELOX



Sales & Book Value

Annual SalesN/A



Market Cap$118.81 million
Next Earnings DateN/A
OptionableNot Optionable
-0.07 (-2.31 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Eloxx Pharmaceuticals (OTCMKTS:ELOX) Frequently Asked Questions

How has Eloxx Pharmaceuticals' stock price been impacted by COVID-19?

Eloxx Pharmaceuticals' stock was trading at $2.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ELOX stock has increased by 2.8% and is now trading at $2.96.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Eloxx Pharmaceuticals?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eloxx Pharmaceuticals

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals, Inc. (OTCMKTS:ELOX) posted its quarterly earnings results on Thursday, August, 6th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.21) by $0.01.
View Eloxx Pharmaceuticals' earnings history

What price target have analysts set for ELOX?

5 brokerages have issued 12-month price objectives for Eloxx Pharmaceuticals' shares. Their forecasts range from $3.00 to $10.00. On average, they expect Eloxx Pharmaceuticals' share price to reach $5.80 in the next year. This suggests a possible upside of 95.9% from the stock's current price.
View analysts' price targets for Eloxx Pharmaceuticals

Who are some of Eloxx Pharmaceuticals' key competitors?

What other stocks do shareholders of Eloxx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eloxx Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), VIVUS (VVUS), Opko Health (OPK), Arbutus Biopharma (ABUS), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), SCYNEXIS (SCYX), Cerecor (CERC) and Precigen (PGEN).

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the following people:
  • Dr. Gregory Williams M.B.A., Ph.D., MBA, CEO & Director (Age 61, Pay $586.7k)
  • Dr. Silvia Noiman M.B.A., Ph.D., MBA, Founder & Director (Age 64, Pay $40k)
  • Mr. Neil S. Belloff Esq., COO, Gen. Counsel & Corp. Sec. (Age 60)
  • Mr. Stephen MacDonald, VP of Fin. & Accounting, Principal Accounting Officer and Treasurer (Age 49)
  • Ms. Barbara Ryan, Investor Relations Officer
  • Ms. Rose Villandry, VP of HR
  • Dr. Thomas Haverty M.D., Chief Medical Officer
  • Mr. Matthew Goddeeris Ph.D., VP of Research

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ELOX."

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $2.96.

How big of a company is Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals has a market capitalization of $118.81 million. Eloxx Pharmaceuticals employs 29 workers across the globe.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is www.eloxxpharma.com.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at 858-909-0749 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.